ADRONALINE
Board
2 directors, no change since 2023Statutory director
appointed by deed of 12-11-2018
term without a fixed end
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 17-07-2026
Statutory director
appointed by deed of 23-11-2023
listed in the 2025 annual accounts, filed on 17-07-2026
Mandates through the years
2 names, the dashed line is todayStatutory manager
Statutory director
Boardmandate already running before its first mention
Mandates as a list
-
- Statutory manager, appointed by deed of 12-11-2018, still in office
-
- Statutory director, since before 31-12-2021
Control
Founders
,
This company
ADRONALINE
Equity €953
Loss €9,906 in 2025
Capital
- Contribution
- €6,200
- Shares
- 100
- Contribution per share
- €62
- Equity per share
- €9.53 in 2025
- Source
- 2025 annual accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 23-11-2023 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 18:00deed of 12-11-2018 (in French)
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Dans les deux mois de la date à laquelle situation constatée ou aurait dû l’être, décider dissolution ou mesures annoncées dans l’ordre du…”deed of 23-11-2023 (in French)
Shareholders
At incorporation
deed of 12-11-2018 ↗
- 97 shares (97%)
- 3 shares (3%)